The University of South Florida St. Petersburg is a branch campus of the University of South Florida in St. Petersburg, Florida. Opened in 1965 as a satellite campus of the University of South Florida, it was consolidated with the other two USF campuses as of July 1, 2020.

During the past decade, University of South Florida conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 10 clinical trials were completed, i.e. on average, 125% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 4 clinical trials were completed. i.e. 133.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of South Florida" #1 sponsor was "University of South Florida" with 9 trials, followed by "Emalex Biosciences Inc." with 2 trials sponsored, "Shire" with 2 trials sponsored, "Sunovion" with 2 trials sponsored and "Duke University" with 2 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of South Florida" #1 collaborator was "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 3 trials as a collaborator, "Indiana University" with 1 trials as a collaborator, "Jeffrey Modell Foundation" with 1 trials as a collaborator, "Massachusetts General Hospital" with 1 trials as a collaborator and "Merck Sharp & Dohme LLC" with 1 trials as a collaborator. Other collaborators include 2 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "University of South Florida" are "HIV Infections" (4 trials), "Obsessive-compulsive Disorder" (4 trials), "Autism" (3 trials), "Attention Deficit Hyperactivity Disorder (ADHD)" (2 trials) and "Obsessive-Compulsive Disorder" (2 trials). Many other conditions were trialed in "University of South Florida" in a lesser frequency.

Most popular intervention types in "University of South Florida" are "Drug" (15 trials), "Behavioral" (6 trials) and "Biological" (5 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Cognitive-behavioral therapy" (3 trials), "Ecopipam" (2 trials), "SPD489" (2 trials) and "Acyclovir" (1 trials). Other intervention names were less common.

The vast majority of trials in "University of South Florida" are 25 trials for "All" genders.

Currently, there are NaN active trials in "University of South Florida". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 19 completed trials in University of South Florida, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in University of South Florida, 2 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 6 trials that are defined as “Not Applicable".